Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
about
Statins for the primary prevention of cardiovascular diseaseStatins for the primary prevention of cardiovascular diseaseJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trialUnanswered ethical and scientific questions for trials of invasive interventions for coronary disease: The case of single vessel diseaseDebate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR surveyThe use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary interventionCurrent medical management of chronic stable anginaGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyLipid-lowering update 2001. Aggressive new goalsRacial Differences in the Cholesterol-Lowering Effect of Statin.Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.Sensors 2010Chronic coronary artery disease: diagnosis and managementNon-lipid-related effects of statins.Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other DyslipidemiasSigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials.Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery.Twenty questions on atherosclerosis.Atorvastatin.Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?Lipid disorders in patients with type 2 diabetes. Meeting the challenges of early, aggressive treatment.Investigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT studyAchievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).The anti-ischemic and anti-anginal properties of statinsQuality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal populationRosuvastatin for the treatment of patients with hypercholesterolemia.Interactions of nitric oxide and peroxynitrite with low-density lipoprotein.Coronary revascularization: an opportunity for lipid screening and treatment.Aggressive secondary prevention: a perspective from the coronary interventional setting.Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemiaThe importance of lipid evaluation and management in the prevention and treatment of acute myocardial infarction.Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician surveyDiagnosis and management of lipoprotein abnormalities.Early statin therapy for acute coronary syndromes.Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors.
P2860
Q24201513-4AE15B9A-5DE9-47F9-A1AA-746CB7402AC9Q24234813-4FE0E17F-3DFF-43BA-A31B-8E2FF2A65BF2Q24630160-F6B332BD-870F-42EC-A83C-6F284D6BE025Q24676024-C8BC871A-540A-4499-8A8F-AF839BF2B778Q24791746-098C872E-E4A8-4E55-96C6-0E8ADC7FE162Q24793512-C13EB90C-D526-4D8D-9A02-B70679101847Q28193412-F82B72F0-7FF4-4DA6-A824-F18E047DA5C2Q28196775-CA9B3D68-526D-4718-9DB0-C1F8DB2041B1Q28213164-302B3104-DBD9-4B18-AF2D-3070DD1E1428Q28239975-D00432FE-316D-4133-9C8F-EAEF44CE5A11Q28354365-2DEA4C0F-6C37-442B-ACDC-9C2184FEB133Q30244632-066269F5-44C7-41F0-98AF-FDCAC1C9AC2EQ30319078-8D6356A4-0C34-47FB-9112-9D213F853731Q30429019-4168C456-EFB6-4A17-9A17-1602CC986BCEQ30430614-335334E9-BBC0-4000-AF4C-9A2FEA3BF199Q30475900-E7145BAB-D657-442C-81A4-97E925EEA91EQ30492121-F1E5520A-1425-46C6-BD3C-B7837A56C5DAQ33924588-CC796488-CFDF-4C77-9FCA-9DF5E9F5599FQ34037840-7E5A75B0-32C0-4A76-BD4B-344D29E17ACCQ34041102-C1E2A339-5C94-4725-8CF2-C0DD5E9C5B45Q34122524-8C501AF0-3CA0-4738-BDE1-3F711C9E70BBQ34135786-1970F801-E0A1-4326-95FA-844BDC6FA00DQ34212434-E8CE307E-BF52-4777-B4D0-6A1569043032Q34241040-E54B66A9-CB19-4CDB-BD02-A2EE974B038FQ34255430-D21C3812-3258-435A-8782-31875527D9B7Q34315710-CA36037C-C09B-4A9D-830A-F550AC35DC02Q34319896-A36837CE-A880-4BB1-B361-3078220EB2E5Q34364029-878B3F13-622D-4A49-AFCC-F9564773BB7AQ34477330-315A532C-4F88-4BE1-944F-2B3A58104F54Q34498277-0526027D-3E6E-4470-8858-31E2AEC9338BQ34509418-AA283AA7-56F9-493D-B58F-7F25C9E934F2Q34658962-74B7E21E-FDA5-41A2-982B-30DD3D9BC6EAQ34675074-A98C46B7-FE1E-4158-B211-9B0FF5E5948EQ34675265-85153B90-0C4F-4E66-B106-3C2B31F61D9FQ34704310-C0586201-42BF-4D90-8042-CEB3ADC349FEQ34714717-06C91DAA-771A-4E8A-8EF3-A5FCA091BDEDQ34743538-75A8B75C-F23F-4D38-BA6D-6EFA3C7BCCCFQ34755683-5AA61D73-8A93-4871-8018-8ED83718141BQ34979669-3CF728CA-AA1E-4687-8FB7-8081137D9210Q35009456-145C15EE-FA08-4469-A54D-46AAD0F0991D
P2860
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@en
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@nl
type
label
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@en
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@nl
prefLabel
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@en
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@nl
P2093
P1476
Aggressive lipid-lowering ther ...... ation Treatment Investigators.
@en
P2093
Eisenberg D
McCormick LS
Schwartz L
Shurzinske L
van Boven AJ
P356
10.1056/NEJM199907083410202
P407
P577
1999-07-01T00:00:00Z